UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047191
Receipt number R000053831
Scientific Title Management and Treatment for Radiation-Induced Colitis
Date of disclosure of the study information 2022/03/22
Last modified on 2022/03/17 14:08:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Management and Treatment for Radiation-Induced Colitis

Acronym

MATRICS

Scientific Title

Management and Treatment for Radiation-Induced Colitis

Scientific Title:Acronym

MATRICS

Region

Japan


Condition

Condition

Locally recurrent colorectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to clarify the frequency and severity of radiation-induced colitis that occurs after heavy ion therapy in patients with locally recurrent colorectal cancer with a high degree of proximity or invasion of the tumor to the gastrointestinal tract.
Based on the appropriate endoscopic observation and evaluation of the colitis, we evaluate the safety of surgical treatment for those cases in which it is indicated.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The frequency and severity of radiation-induced colitis that occurs within two years after heavy ion therapy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Heavy-ion radiation therapy 73.6Gy/16fr/4weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Locally recurrent colorectal diseases.
2) Tumor invades or is in close proximity to the gastrointestinal tract, and the site can be observed by colonoscopy.
3) The tumor is not indicated for curative resection.
4) Surgeons at the collaborating institution have previously evaluated that resection of the damaged gastrointestinal tract is feasible.
5) The patient has no distant metastases or has only metastatic lesions that are scheduled for resection.
6) Be at least 20 years of age at the time of enrollment.
7) Patient has a performance status (ECOG) of 0-1.
8) Main organ function is preserved.
9) Written consent for participation in this study has been obtained from the patient.

Key exclusion criteria

1) Patients who are considered to be unable to undergo the prescribed hospital visits and examinations.
2) Patients who are receiving chemotherapy or who have not completed chemotherapy within 2 weeks of the start of irradiation.
3) Patients with open wounds or active, refractory infections in the irradiated area.
4) Patients have active multiple cancers.
5) Patients with serious complications.
6) Patients with mental illness or psychiatric symptoms that would make participation in the clinical research difficult or adults who are incapable of consenting.
(7) Patients who are considered to be unsuitable for enrollment in this study by the physician.

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Hirotoshi
Middle name
Last name Takiyama

Organization

National Institutes for Quantum Science and Technology

Division name

QST Hospital

Zip code

263-8555

Address

4-9-1 Anagawa, Inage, Chiba City, Chiba Pref.

TEL

0432063306

Email

takiyama.hirotoshi@qst.go.jp


Public contact

Name of contact person

1st name Hirotoshi
Middle name
Last name Takiyama

Organization

National Institutes for Quantum Science and Technology

Division name

QST Hospital

Zip code

263-8555

Address

4-9-1 Anagawa, Inage, Chiba City, Chiba Pref.

TEL

0432063306

Homepage URL


Email

takiyama.hirotoshi@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum Science and Technology

Institute

Department

Personal name



Funding Source

Organization

National Institutes for Quantum Science and Technology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Institutes for Quantum Science and Technology Certified Review Board

Address

4-9-1 Anagawa, Inage, Chiba City, Chiba Pref.

Tel

043-206-4706

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立国際医療研究センター病院


Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 11 Month 24 Day

Date of IRB

2022 Year 03 Month 11 Day

Anticipated trial start date

2022 Year 03 Month 22 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 17 Day

Last modified on

2022 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053831